Heparin Cause Hyperkalemia Online

Heparin, a widely used anticoagulant, is essential in the prevention and treatment of thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and acute coronary syndromes. While its anticoagulant effects are well-recognized, a less familiar but clinically significant adverse effect is hyperkalemia—an elevated serum potassium level that can lead to life-threatening cardiac arrhythmias and muscle weakness. Although heparin-induced hyperkalemia is often mild and asymptomatic, it can become severe, particularly in patients with underlying risk factors. This essay examines the pathophysiology, clinical presentation, risk factors, and management strategies of hyperkalemia caused by heparin and its low-molecular-weight derivatives.

Heparin-Induced Hyperkalemia: Mechanisms, Risk Factors, and Clinical Implications heparin cause hyperkalemia

Heparin-induced hyperkalemia is reversible upon drug discontinuation. Aldosterone production typically recovers within days to weeks after stopping heparin. However, unrecognized severe hyperkalemia can lead to cardiac arrest and death. Therefore, awareness and monitoring are critical, particularly in hospitalized patients receiving therapeutic-dose heparin. Heparin, a widely used anticoagulant, is essential in

Heparin-induced hyperkalemia usually develops after initiation of therapy, though it can occur as early as 48 hours in susceptible individuals. The rise in serum potassium is generally modest (0.5–1.5 mEq/L above baseline), but increases of >6.0 mEq/L have been reported. Many patients remain asymptomatic, with hyperkalemia detected only on routine laboratory monitoring. When symptoms occur, they are nonspecific and include fatigue, palpitations, nausea, and muscle weakness. Electrocardiographic changes (peaked T waves, widened QRS, bradycardia, and eventually ventricular fibrillation or asystole) may appear at potassium levels above 6.5 mEq/L. Electrocardiographic changes (peaked T waves